EGFR and lung adenocarcinoma: Here, we present this unique case of a Chinese woman who was confirmed as late stage lung adenocarcinoma with intraventricular metastases without parenchyma lesions and had a good response to target therapy with Epidermal Growth Factor Receptor- tyrosine kinase inhibitor (EGFR-TKI).